| Year |
Citation |
Score |
| 2015 |
Kang Q, Ru Q, Liu Y, Xu L, Liu J, Wang Y, Zhang Y, Li H, Zhang Q, Wu Q. On-line monitoring the extract process of Fu-fang Shuanghua oral solution using near infrared spectroscopy and different PLS algorithms. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 152: 431-437. PMID 26241829 DOI: 10.1016/j.saa.2015.07.098 |
0.398 |
|
| 2015 |
Lovell MA, Abner E, Kryscio R, Xu L, Fister SX, Lynn BC. Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxidative Medicine and Cellular Longevity. 2015: 787805. PMID 26221415 DOI: 10.1155/2015/787805 |
0.572 |
|
| 2014 |
Wei S, Xu L, Kryscio RJ. Markov Transition Model to Dementia with Death as a Competing Event. Computational Statistics & Data Analysis. 80: 78-88. PMID 25110380 DOI: 10.1016/J.Csda.2014.06.014 |
0.509 |
|
| 2010 |
Nelson PT, Jicha GA, Kryscio RJ, Abner EL, Schmitt FA, Cooper G, Xu LO, Smith CD, Markesbery WR. Low sensitivity in clinical diagnoses of dementia with Lewy bodies. Journal of Neurology. 257: 359-66. PMID 19795154 DOI: 10.1007/S00415-009-5324-Y |
0.577 |
|
| 2009 |
Nelson PT, Kryscio RJ, Jicha GA, Abner EL, Schmitt FA, Xu LO, Cooper G, Smith CD, Markesbery WR. Relative preservation of MMSE scores in autopsy-proven dementia with Lewy bodies. Neurology. 73: 1127-33. PMID 19805729 DOI: 10.1212/Wnl.0B013E3181Bacf9E |
0.602 |
|
| 2009 |
Schmitt FA, Kryscio RJ, Xu L, Mendiondo M, Caban-Holt A, Abner E, Runyons C, Markesbery WR. P1-277: Effects of repeated screening and potential impact on AD prevention trial design: The antioxidant AD prevention (PREADVISE) trial Alzheimer's & Dementia. 5: P258-P258. DOI: 10.1016/J.Jalz.2009.04.285 |
0.534 |
|
| Show low-probability matches. |